|
|
Non-Hodgkin's Lymphoma
The Basics
Research
- Good Survival for HIV Patients Diagnosed With Non-Hodgkin's Lymphoma (June 22, 2009)
From aidsmap.com
- HAART Signicantly Lowers Risk of Non-Hodgkin's Lymphoma for up to Ten Years, Regardless of Nadir CD4 Count (January 15, 2008)
From aidsmap.com
- Incidence of AIDS-Associated and Non-AIDS-Associated Malignancies Among HIV-Infected Individuals (February 6, 2006)
Recent studies examine the risks for Kaposi's sarcoma, non-Hodgkin's lymphoma, cervical cancer, lung cancer and other malignancies.
In The 13th Conference on Retroviruses and Opportunistic Infections
- HAART Reduces Incidence and Improves Long-Term Prognosis of Non-Hodgkin's Lymphoma (July 15, 2004)
In The XV International AIDS Conference, from The Body PRO
- Non-Hodgkin's Lymphoma Rates Lower in HAART-Treated Patients (July 12, 2004)
In The XV International AIDS Conference, from The Body PRO
Support & Resources
|
Advertisement
|